Drug Shortage Report for PLERIXAFOR INJECTION
Report ID | 223974 |
Drug Identification Number | 02529815 |
Brand name | PLERIXAFOR INJECTION |
Common or Proper name | Plerixafor Injection |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | PLERIXAFOR |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 x 1.2 mL |
ATC code | L03AX |
ATC description | IMMUNOSTIMULANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-03-29 |
Estimated end date | 2024-07-31 |
Actual end date | 2024-04-30 |
Shortage status | Resolved |
Updated date | 2024-05-01 |
Company comments | Short dated avaiable |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-05-01 | English | Compare |
v8 | 2024-04-30 | French | Compare |
v7 | 2024-04-30 | English | Compare |
v6 | 2024-04-17 | French | Compare |
v5 | 2024-04-17 | English | Compare |
v4 | 2024-04-02 | French | Compare |
v3 | 2024-04-02 | English | Compare |
v2 | 2024-03-30 | French | Compare |
v1 | 2024-03-30 | English | Compare |
Showing 1 to 9 of 9